Results 161 to 170 of about 55,212 (214)

BCOR Mutations Deregulate Cell Cycle and Hypoxic Adaptation Pathways in Retinoblastoma. [PDF]

Mol Cancer Res
Zhang MG, Kuznetsoff JN, Cetta NC, Salazar S, Volonterio RL, Kurtenbach S, Correa ZM, Pelaez D, Harbour JW.   +8 more
europepmc   +1 more source

Provider and caregiver perspectives on vision services for childhood cancer survivors: a qualitative study. [PDF]

BMC Health Serv Res
Parvathaneni A, Zabotka L, Strelnikov J, L'Hotta AJ, Ehrhardt MJ, Montoya M, Thallapureddy K, Hayashi RJ, Reynolds M, Malone S.   +9 more
europepmc   +1 more source

Extraskeletal osteosarcoma arising in the globe of an irradiated, heritable retinoblastoma survivor. [PDF]

Am J Ophthalmol Case Rep
Andoh JE, Stone FE, Wade-Vallance I, Thangamathsavaran L, Mei F, Dharssi S, Gross JM, Mahoney N, Handa JT, Eberhart C.   +9 more
europepmc   +1 more source

Fight retinoblastoma India: A decade of collective action, collaboration, and patient-centered care. [PDF]

Indian J Ophthalmol
Bagai P, Honavar SG, Mahajan A, Das S, Gupta H.   +4 more
europepmc   +1 more source

Recurrent Bronchospasm During Intra-arterial Chemotherapy via IMAX Access for Retinoblastoma: A Case Report. [PDF]

Cureus
Huang R, Muthu P, Najera M.
europepmc   +1 more source

Revisiting low penetrance retinoblastoma: an integrated clinical, genetic, and bioinformatic analysis. [PDF]

Hum Mol Genet
Avnat E, Shapira G, Lustig Y, Citrin J, Rojanaporn D, Kaewkhaw R, Jo DH, Kim JH, Shomron N, Friedman E, Fabian ID.   +10 more
europepmc   +1 more source

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma. [PDF]

Sci Rep
Sujjitjoon J, Ng WL, Kongkla K, Jarutatsanangkoon K, Chongsutakawewong K, Subhadhirasakul S, Uiprasertkul M, Udompunturak S, Junking M, Yenchitsomanus PT, Atchaneeyasakul LO.   +10 more
europepmc   +1 more source

Retinoblastoma in times of war: changing patterns of presentation, treatment, and prognosis in Gaza. [PDF]

Front Oncol
Yousef YA, Msallam M, Mohammad M, Halalsheh H, Khzouz J, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, Al-Nawaiseh I, Mansour A.   +11 more
europepmc   +1 more source

Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response. [PDF]

Invest Ophthalmol Vis Sci
Wang M, Tang J, Li J, Lv J, Zhang Z, Liu Y, Sun H, Gao Y, Chen S, Tang L, Zhang P, Su S, Lu R.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Retinoblastoma

Current Opinion in Ophthalmology, 2013
Retinoblastoma is the most common malignant intraocular tumor of childhood. Treatment and diagnostic modalities associated to this condition are changing rapidly as our understanding of this condition crystallizes. The purpose of this review is to provide an update of the current understanding of retinoblastoma.Knowledge on tumorigenesis and genomic ...
Victor M, Villegas, Ditte J, Hess, Andrea, Wildner, Aaron S, Gold, Timothy G, Murray   +4 more
openaire   +4 more sources